Vertex Pharmaceuticals
VRTX
VRTX
488 hedge funds and large institutions have $20.9B invested in Vertex Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 188 increasing their positions, 178 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
488
Holders Change
+8
Holders Change %
+1.67%
% of All Funds
13.04%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
45
Increased
188
Reduced
178
Closed
34
Calls
$95.6M
Puts
$87.9M
Net Calls
+$7.73M
Net Calls Change
+$7.24M
Top Buyers
| 1 |
Jennison Associates
New York
|
$452M |
| 2 |
State Street
Boston,
Massachusetts
|
$1,000M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
$2B |
| 4 |
Capital World Investors
Los Angeles,
California
|
$1.94B |
| 5 |
Morgan Stanley
New York
|
$63.3M |
Top Sellers
| 1 |
GE
General Electric
Evendale,
Ohio
|
$0 |
| 2 |
JPMorgan Chase & Co
New York
|
$962M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
$63.9M |
| 4 |
O
OrbiMed
New York
|
$141M |
| 5 |
D.E. Shaw & Co
New York
|
$39.1M |
